AAAAAA
Results:
1-21
|
Results: 21
Authors:
Dal Bello-Haas, V
Andrews-Hinders, D
Richer, CB
Blakely-Adams, C
Hanson, J
Hammel, J
Kelly, D
Kloos, A
Pioro, EP
Powazki, RD
Wheeler, T
Mitsumoto, H
Citation: V. Dal Bello-haas et al., Development, analysis, refinement, and utility of an interdisciplinary amyotrophic lateral sclerosis database, AMYOTROPH L, 2(1), 2001, pp. 39-46
Authors:
Mitsumoto, H
Citation: H. Mitsumoto, Clinical trials: present and future, AMYOTROPH L, 2, 2001, pp. S10-S14
Authors:
Mitsumoto, H
Klinkosz, B
Pioro, EP
Tsuzaka, K
Ishiyama, T
O'Leary, RM
Pennica, D
Citation: H. Mitsumoto et al., Effects of cardiotrophin-1 (CT-1) in a mouse motor neuron disease, MUSCLE NERV, 24(6), 2001, pp. 769-777
Authors:
Tsuzaka, K
Ishiyama, T
Pioro, EP
Mitsumoto, H
Citation: K. Tsuzaka et al., Role of brain-derived neurotrophic factor in wobbler mouse motor neuron disease, MUSCLE NERV, 24(4), 2001, pp. 474-480
Authors:
Aboussouan, LS
Khan, SU
Banerjee, M
Arroliga, AC
Mitsumoto, H
Citation: Ls. Aboussouan et al., Objective measures of the efficacy of noninvasive positive-pressure ventilation in amyotrophic lateral sclerosis, MUSCLE NERV, 24(3), 2001, pp. 403-409
Authors:
Albert, SM
Murphy, PL
Del Bene, M
Rowland, LP
Mitsumoto, H
Citation: Sm. Albert et al., Incidence and predictors of PEG placement in ALS/MND, J NEUR SCI, 191(1-2), 2001, pp. 115-119
Authors:
Mitsumoto, H
Del Bene, M
Citation: H. Mitsumoto et M. Del Bene, Improving the quality of life for people with ALS: The challenge ahead, AMYOTROPH L, 1(5), 2000, pp. 329-336
Authors:
Dal Bello-Haas, V
Andrews-Hinders, D
Bocian, J
Mascha, E
Wheeler, T
Mitsumoto, H
Citation: V. Dal Bello-haas et al., Spiritual well-being of the individual with amyotrophic lateral sclerosis, AMYOTROPH L, 1(5), 2000, pp. 337-341
Authors:
Dynes, GJ
Schwimer, CJ
Staugaitis, SM
Doyle, JJ
Hays, AP
Mitsumoto, H
Citation: Gj. Dynes et al., Amyotrophic lateral sclerosis with multiple sclerosis: A clinical and pathological report, AMYOTROPH L, 1(5), 2000, pp. 349-353
Authors:
Mitsumoto, H
Citation: H. Mitsumoto, GDNF is trophic for mouse motoneurons that express a mutant superoxide dismutase (SOD1) gene, AMYOTROPH L, 1(2), 2000, pp. 69-70
Authors:
Hentati, A
Deng, HX
Zhai, H
Chen, W
Yang, Y
Hung, WY
Azim, AC
Bohlega, S
Tandan, R
Warner, C
Laing, NG
Cambi, F
Mitsumoto, H
Roos, RP
Boustany, RM
Ben Hamida, M
Hentati, F
Siddique, T
Citation: A. Hentati et al., Novel mutations in spastin gene and absence of correlation with age at onset of symptoms, NEUROLOGY, 55(9), 2000, pp. 1388-1390
Authors:
Miller, RG
Anderson, FA
Bradley, WG
Brooks, BR
Mitsumoto, H
Munsat, TL
Ringel, SP
Citation: Rg. Miller et al., The ALS Patient Care Database - Goals, design, and early results, NEUROLOGY, 54(1), 2000, pp. 53-57
Authors:
Esposito, SJ
Mitsumoto, H
Shanks, M
Citation: Sj. Esposito et al., Use of palatal lift and palatal augmentation prostheses to improve dysarthria in patients with amyotrophic lateral sclerosis: A case series, J PROS DENT, 83(1), 2000, pp. 90-98
Authors:
Mitsumoto, H
Tsuzaka, K
Citation: H. Mitsumoto et K. Tsuzaka, Neurotrophic factors and neuromuscular disease: I. General comments, the neurotrophin family, and neuropoietic cytokines - II. GDNF, other neurotrophic factors, and future directions, MUSCLE NERV, 22(8), 1999, pp. 983-1021
Authors:
Miller, RG
Rosenberg, JA
Gelinas, DF
Mitsumoto, H
Newman, D
Sufit, R
Borasio, GD
Bradley, WG
Bromberg, MB
Brooks, BR
Kasarskis, EJ
Munsat, TL
Oppenheimer, EA
Citation: Rg. Miller et al., Practice parameter: The care of the patient with amyotrophic lateral sclerosis (an evidence-based review), MUSCLE NERV, 22(8), 1999, pp. 1104-1118
Authors:
Dal Bello-Haas, V
Kloos, AD
Mitsumoto, H
Citation: V. Dal Bello-haas et al., Maintaining quality of life - Response, PHYS THER, 79(4), 1999, pp. 423-424
Authors:
Mitsumoto, H
Citation: H. Mitsumoto, Patient choices in ALS - Life-sustaining treatment versus palliative care?, NEUROLOGY, 53(2), 1999, pp. 248-249
Authors:
Pioro, EP
Majors, AW
Mitsumoto, H
Nelson, DR
Ng, TC
Citation: Ep. Pioro et al., H-1-MRS evidence of neurodegeneration and excess glutamate plus glutamine in ALS medulla, NEUROLOGY, 53(1), 1999, pp. 71-79
Authors:
Miller, RG
Rosenberg, JA
Gelinas, NF
Mitsumoto, H
Newman, D
Sufit, R
Borasio, GD
Bradley, WG
Bromberg, MB
Brooks, BR
Kasarskis, EJ
Munsat, TL
Oppenheimer, EA
Citation: Rg. Miller et al., Practice parameter: The care of the patient with amyotrophic lateral sclerosis (an evidence-based review) - Report of the Quality Standards Subcommittee of the American Academy of Neurology, NEUROLOGY, 52(7), 1999, pp. 1311-1323
Authors:
Kasarskis, EJ
Shefner, JM
Miller, R
Smith, RA
Licht, J
Mitsumoto, H
Hopkins, LC
Rosenfeld, J
Pascuzzi, R
Cornblath, DR
Armon, C
Strong, MJ
Kula, R
Windebank, A
Bosch, EP
Smith, BE
Cashman, N
Sivak, M
Sergay, S
Siddique, T
Sufit, RL
Johnston, W
Brooke, MB
Graves, MC
Olney, RK
Roos, RP
Neville, H
Ringel, SP
Ross, M
Bradley, WG
Sharma, KR
Parry, G
Mandler, R
Giuliani, M
Thornton, CA
Jackson, C
Bryan, W
Bromberg, M
Tandan, R
Fries, T
Phillips, L
Brooks, BR
Fenichel, G
Pestronk, A
Bear, M
Beatey, R
Fuller, C
Hill, R
Malta, E
Nakanishi, A
Patel, A
Thurmond, B
Cedarbaum, JM
Stambler, N
Citation: Ej. Kasarskis et al., A controlled trial of recombinant methionyl human BDNF in ALS, NEUROLOGY, 52(7), 1999, pp. 1427-1433
Authors:
Dal Bello-Haas, V
Kloos, AD
Mitsumoto, H
Citation: V. Dal Bello-haas et al., Physical therapy for a patient through six stages of amyotrophic lateral sclerosis, PHYS THER, 78(12), 1998, pp. 1312-1324
Risultati:
1-21
|